Xiaoxi Lin Selected Research

Xiaoxi Lin Research Topics

Disease

26	Hemangioma (Angioma) 12/2023 - 03/2002
19	Port-Wine Stain (Nevus Flammeus) 11/2023 - 03/2015
9	Cicatrix (Scar) 03/2024 - 11/2009
6	Pain (Aches) 12/2023 - 03/2017
4	Vascular Malformations 11/2023 - 03/2002
4	Arteriovenous Malformations (Arteriovenous Malformation) 11/2022 - 01/2018
4	Hyperpigmentation 05/2022 - 03/2015
4	Congenital Abnormalities (Deformity) 01/2022 - 10/2019
3	Pigmented Nevus (Melanocytic Nevus) 03/2024 - 10/2019
3	Erythema 11/2023 - 03/2015
3	Acne Vulgaris 02/2023 - 11/2009
3	Neoplasms (Cancer) 01/2023 - 02/2016
3	Infections 01/2023 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 12/2022
2	Melanoma (Melanoma, Malignant) 12/2021 - 08/2020
2	Hemorrhage 01/2021 - 03/2017
2	Paralysis (Palsy) 01/2021 - 06/2008
2	Fever (Fevers) 03/2015 - 06/2008
1	Adenocarcinoma 05/2024
1	Rare Diseases (Rare Disease) 05/2024
1	Hemimegalencephaly 11/2023
1	Lipomatosis 11/2023
1	Sepsis (Septicemia) 11/2023
1	Nevus (Nevi) 11/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Fatigue 01/2023
1	Cushing Syndrome 01/2023
1	Adenoma (Adenomas) 01/2023
1	Leukocytosis (Pleocytosis) 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	Kaposiform Hemangioendothelioma 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Reperfusion Injury 12/2022
1	Inflammation (Inflammations) 12/2022
1	Neurofibroma 07/2022
1	Circulating Neoplastic Cells 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Hypertrophy 09/2021

Drug/Important Bio-Agent (IBA)

12	Propranolol (Inderal)FDA LinkGeneric 12/2023 - 02/2014
4	Timolol (Blocadren)FDA LinkGeneric 08/2022 - 05/2014
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022 - 03/2015
3	Ethanol (Ethyl Alcohol)IBA 11/2023 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2022
3	bleomycetinIBA 01/2022 - 06/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2002
3	hematoporphyrin monomethyl etherIBA 04/2020 - 01/2016
3	PlasticsIBA 01/2020 - 06/2017
3	CytokinesIBA 01/2019 - 03/2002
3	Bleomycin (Blenoxane)FDA LinkGeneric 04/2018 - 03/2015
2	Melanins (Melanin)IBA 11/2023 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2016
2	Sirolimus (Rapamycin)FDA Link 01/2023 - 01/2018
2	Botulinum Toxins (Botulinum Toxin)IBA 01/2019 - 01/2018
2	Anesthetics (Anesthetic Agents)IBA 04/2018 - 03/2017
2	MicroRNAs (MicroRNA)IBA 01/2018 - 02/2016
2	Imiquimod (Aldara)FDA LinkGeneric 05/2013 - 05/2011
2	EnzymesIBA 07/2005 - 03/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2005 - 03/2002
2	ImmunosorbentsIBA 07/2005 - 03/2002
1	Immunoglobulin A (IgA)IBA 03/2024
1	Betamethasone (Celestone)FDA Link 12/2023
1	InterleukinsIBA 11/2023
1	Interleukin-17 (Interleukin 17)IBA 11/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2023
1	Dabigatran FDA Link 03/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2023
1	ProcalcitoninIBA 01/2023
1	Apelin ReceptorsIBA 01/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	Tissue Adhesives (Tissue Adhesive)IBA 12/2022
1	ProdrugsIBA 08/2022
1	Long Noncoding RNAIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 12/2021
1	NanogelsIBA 12/2021
1	Liposomes (Liposome)IBA 12/2021
1	Monophenol Monooxygenase (Tyrosinase)IBA 12/2021
1	Tranexamic Acid (AMCA)FDA Link 12/2021

Therapy/Procedure

13	Dye Lasers 01/2022 - 03/2016
9	Lasers (Laser) 03/2024 - 11/2009
9	Therapeutics 01/2023 - 07/2005
6	Photochemotherapy (Photodynamic Therapy) 03/2022 - 03/2015
5	Injections 01/2022 - 03/2015
3	Solid-State Lasers 03/2024 - 05/2014
3	Anesthesia 12/2023 - 03/2017
3	Laser Therapy (Surgery, Laser) 09/2021 - 03/2015
3	Blepharoplasty 10/2019 - 01/2017
2	Sclerotherapy 03/2022 - 03/2020
2	Tissue Expansion Devices (Tissue Expander) 01/2020 - 12/2019
2	Rhinoplasty 01/2018 - 06/2017
1	Drug Therapy (Chemotherapy) 05/2024
1	Aftercare (After-Treatment) 03/2024
1	Therapeutic Embolization 11/2023
1	Percutaneous Collagen Induction 02/2023
1	Ischemic Postconditioning 12/2022
1	Combined Modality Therapy 11/2022
1	Intense Pulsed Light Therapy 05/2022